In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD). Memantine is an uncompetitive N-methyl-D-aspartate ...

Nystagmus is characterized by involuntary to and fro movement of the eyes. There is evidence to indicate that memantine and gabapentin can reduce acquired nystagmus, but these drugs have not been ...

Find all the commercial and brand names of generic drug called Memantine. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

(Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules ...

The company announced today that it has launched memantine/donepezil extended-release capsules for Alzheimer's-related dementia, with an exclusive 180-day marketing period. Additionally ...

Consequently, combination therapy currently involves the administration of one cholinergic drug (donepezil, galantamine or rivastigmine) and one glutamatergic drug (memantine). There have been no ...